3/27
02:24 pm
rckt
Rocket Pharmaceuticals (RCKT) had its "buy" rating reaffirmed by Chardan Capital. They now have a $11.00 price target on the stock.
Low
Report
Rocket Pharmaceuticals (RCKT) had its "buy" rating reaffirmed by Chardan Capital. They now have a $11.00 price target on the stock.
3/27
02:23 pm
rckt
Rating for RCKT
Low
Report
Rating for RCKT
3/2
12:25 pm
rckt
Rating for RCKT
Low
Report
Rating for RCKT
3/2
12:25 pm
rckt
Rating for RCKT
Low
Report
Rating for RCKT
3/2
12:25 pm
rckt
Rating for RCKT
Low
Report
Rating for RCKT
2/27
09:39 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT